IntroductionIn February 2022, BlackBasta emerged as a successor to Conti ransomware and quickly rose to prominence. BlackBasta was operational for three years until February 2025 when their internal ...

AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...

Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...

It’s an age-old story: an innovative robot company with a brilliant idea and some game-changing technology finds itself ...

Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise ...

UK based provider of physical layer IP for 5G non-terrestrial networks (NTN), AccelerComm Ltd, today announced the grant of its 56th international patent, marking a significant milestone as the ...

© 2026 Forbes Media LLC. All Rights Reserved.

© 2026 Forbes Media LLC. All Rights Reserved.

This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

The rise of Africa’s AI factoriesUnpacking the global intelligence infrastructure revolution − and what it means for South Africa. By Eugene Perumal, Eugene Perumal, founder and principal of ...